Albertsons Companies · 2 weeks ago
Per Diem Float Pharmacist
Albertsons Companies is seeking a Per Diem Float Pharmacist who will play a vital role in providing direct patient care and wellness services. This position involves supervising pharmacy technicians, delivering patient care services, and contributing to operational excellence in a dynamic environment.
Food and BeverageFood DeliveryMeat and PoultryRetail
Responsibilities
Actively delivers patient care services
Supervises pharmacy technicians, clerks and pharmacy interns
Embrace and champion operational excellence, ensuring a safe and compliant environment
Contribute actively to the company’s cultural initiatives that enhance overall success and sustainability
Qualification
Required
Bachelor's degree in pharmacy or Pharm.D or equivalent FPGEC (NABP)
Must have an active pharmacy license in state(s) of practice with all held licenses in good standing
Certified Immunizer Required
Ability to work a variety of schedules
Benefits
Competitive Wages
Flexible work schedules
Associate discounts
Leaders invested in your training, career growth & development
Health and welfare benefits for eligible employees (Medical, Dental, 401k and more!)
Vacation / Paid Time Off
OPT, H-1B (H1B) & TN sponsorship or H1B visa transfers may be available
An inclusive work environment with talented colleagues who reflect the communities we serve
Candidates with unique qualifications may be considered for compensation above this range.
Dependent on length of service, hours worked, any applicable collective bargaining agreement and/or Company policy, benefits may include medical, dental, vision, disability and life insurance, sick pay*, PTO/Vacation pay*, paid holidays*, bereavement pay and retirement benefits (pension and/or 401(k) eligibility).
Associates in this position may be eligible for a quarterly bonus, subject to Company bonus plans.
Company
Albertsons Companies
Albertsons Companies is a food and drug retailer that helped in the areas of hunger relief, education, cancer research, and treatment.
Funding
Current Stage
Public CompanyTotal Funding
$5.35BKey Investors
Apollo
2026-01-22Post Ipo Debt· $2.1B
2025-10-21Post Ipo Debt· $1.5B
2022-10-14Acquired
Leadership Team
Recent News
2026-01-23
2026-01-22
Company data provided by crunchbase